Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial.
- DOI
- 10.1016/j.ard.2026.08.020
- Published
- 2026 Sep 22
- Container
- Annals of the rheumatic diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ard.2026.08.020,
title = {Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial.},
author = {Junek M and Ibrahim Q and Merkel PA and Vilayur E and Wald R and Fairhead T and Massicotte-Azarniouch D and Girard L and Pagnoux C and Khalidi N and Jayne D and Walsh M and PEXIVAS investigators},
year = {2026},
journal = {Annals of the rheumatic diseases},
doi = {10.1016/j.ard.2026.08.020},
url = {https://doi.org/10.1016/j.ard.2026.08.020}
}RIS
TY - JOUR TI - Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial. AU - Junek M AU - Ibrahim Q AU - Merkel PA AU - Vilayur E AU - Wald R AU - Fairhead T AU - Massicotte-Azarniouch D AU - Girard L AU - Pagnoux C AU - Khalidi N AU - Jayne D AU - Walsh M AU - PEXIVAS investigators PY - 2026 JO - Annals of the rheumatic diseases DO - 10.1016/j.ard.2026.08.020 UR - https://doi.org/10.1016/j.ard.2026.08.020 ER -
APA
M, J., Q, I., PA, M., E, V., R, W., T, F., D, M., L, G., C, P., N, K., D, J., M, W., & investigators, P. (2026). Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial.. Annals of the rheumatic diseases. https://doi.org/10.1016/j.ard.2026.08.020
Source records
- pubmed · retrieved 2026-09-25T13:09:44.659Z